This article is more than 5 years old. Information may no longer be current.
Cardiology Today’s top prevention stories of 2018
Healio Cardiology compiled a list of the most-read prevention articles from 2018.
Our readers were highly interested in diet and supplementation, as topics such as plant-based diets, vitamins, omega-3 fatty acids and aspirin garnered much attention. Also popular were articles about SGLT2 inhibitors in patients with diabetes, which have demonstrated a variety of CV benefits, as well as coverage of the new cholesterol guidelines.
Vitamins, supplements provide little to no CV health benefit
Most popular vitamins and mineral supplements provide little benefit to CV health, according to a review article published in the Journal of the American College of Cardiology.
PURE: Moderate red meat, dairy intake may help reduce mortality, CV risk
MUNICH — A new diet quality tool based on an analysis of more than 218,000 adults worldwide suggests that increased intake of unprocessed red meat, fish and whole fat dairy can reduce risk for all-cause mortality, MI and stroke, according to new data from the PURE study presented at the European Society of Cardiology Congress.
Plant-based diets reduce CV risk
LAS VEGAS — Plant-based diets can reduce risk for CV-related events and mortality as effectively as pharmacotherapies, according to a presentation at the National Lipid Association Scientific Sessions.
ARRIVE: Aspirin does not reduce initial vascular events in low - to moderate - risk population
MUNICH — In a moderate-risk population with low event rates, aspirin did not significantly reduce initial vascular events, according to the ARRIVE study presented at the European Society of Cardiology Congress.
Cholesterol guidelines updated with newer medications, more personalized risk calculation
CHICAGO — New cholesterol guidelines from the American Heart Association, American College of Cardiology and 10 other societies recommend a stepped approach including statins, ezetimibe and PCSK9 inhibitors in patients with prior CVD at very high risk for another event.
AHA: Diverse diets not necessarily healthy
Encouraging people to eat a variety of foods may have the unintended consequence of consumption of more unhealthy foods, according to a science advisory from the American Heart Association.
ASCEND: Aspirin, omega-3 supplements fail for primary prevention in diabetes
MUNICH — In a large cohort of patients with diabetes but no prior CVD, aspirin prevented vascular events but caused major bleeding events, and an omega-3 fatty acid supplement did not prevent vascular events, researchers from the ASCEND study reported at the European Society of Cardiology Congress.
DECLARE-TIMI 58: Dapagliflozin reduces HF hospitalization in type 2 diabetes
CHICAGO — The DECLARE-TIMI 58 trial of dapagliflozin in patients with type 2 diabetes who had or were at high risk for atherosclerotic CVD adds to the growing body of evidence demonstrating the favorable effects of SGLT2 inhibitors on CV risk.
SGLT2 inhibitor therapies may raise risk for amputation, diabetic ketoacidosis in diabetes with CVD
MUNICH — Adults with type 2 diabetes and established CVD prescribed SGLT2 inhibitor therapy have a twofold increased risk for lower-limb amputation and diabetic ketoacidosis compared with patients prescribed a GLP-1 receptor agonist, according to study findings presented at the European Society of Cardiology Congress.
Proper nutrition can change course of CHD, other diseases
BOSTON — Nutrition is a powerful source of cardioprotective intervention and physicians must be better about incorporating nutritional education into their treatment plans, according to a presentation at the Cardiometabolic Health Congress.